Search research articles
Contact Us
Filters
Showing results (161-170 of 298) with videos related to
Page
of 30
Sort By:
Translational Oncology
|
June 10, 2015
Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics
Stefan Vallo, Martin Michaelis, Florian Rothweiler, et al.
Urologic Oncology
|
August 5, 2019
Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer
Rene Mager, Olga Savko, Katharina Böhm, et al.
World Journal of Urology
|
November 1, 2022
Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences
Maximilian Haack, Vanessa Miksch, Zhe Tian, et al.
World Journal of Urology
|
June 30, 2025
Impact of the PI-QUAL MRI quality score on histopathological up-staging from MRI fusion biopsy to final prostatectomy specimen
Maximilian Haack, Mohamad Turkman, Tobias Jorg, et al.
Cancer Medicine
|
June 26, 2024
Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology
Gregor Duwe, Dominique Mercier, Crispin Wiesmann, et al.
Oncology Letters
|
November 9, 2017
Blocking integrin β1 decreases adhesion in chemoresistant urothelial cancer cell lines
Stefan Vallo, Jochen Rutz, Miriam Kautsch, et al.
Oncology Reports
|
December 29, 2015
Autophagy-associated proteins BAG3 and p62 in testicular cancer
Georg Bartsch, Lukas Jennewein, Patrick N Harter, et al.
BMC Cancer
|
October 6, 2010
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Nina Wagener, Stephan Macher-Goeppinger, Maria Pritsch, et al.
European Urology
|
August 31, 2017
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)
Hendrik Borgmann, Nada Lallous, Deniz Ozistanbullu, et al.
Plos One
|
December 5, 2025
Complications and oncologic outcome in bladder cancer patients receiving radical cystectomy after intravesical instillation treatment
Lisa J Frey, Katarzyna E Banasiewicz, Christian Ruckes, et al.
Page
of 30
Search research articles
Search
Showing results (161-170 of 298) with videos related to
Sort By:
Page
of 30
Translational Oncology
|
June 10, 2015
Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics
Stefan Vallo, Martin Michaelis, Florian Rothweiler, et al.
Urologic Oncology
|
August 5, 2019
Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer
Rene Mager, Olga Savko, Katharina Böhm, et al.
World Journal of Urology
|
November 1, 2022
Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences
Maximilian Haack, Vanessa Miksch, Zhe Tian, et al.
World Journal of Urology
|
June 30, 2025
Impact of the PI-QUAL MRI quality score on histopathological up-staging from MRI fusion biopsy to final prostatectomy specimen
Maximilian Haack, Mohamad Turkman, Tobias Jorg, et al.
Cancer Medicine
|
June 26, 2024
Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology
Gregor Duwe, Dominique Mercier, Crispin Wiesmann, et al.
Oncology Letters
|
November 9, 2017
Blocking integrin β1 decreases adhesion in chemoresistant urothelial cancer cell lines
Stefan Vallo, Jochen Rutz, Miriam Kautsch, et al.
Oncology Reports
|
December 29, 2015
Autophagy-associated proteins BAG3 and p62 in testicular cancer
Georg Bartsch, Lukas Jennewein, Patrick N Harter, et al.
BMC Cancer
|
October 6, 2010
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Nina Wagener, Stephan Macher-Goeppinger, Maria Pritsch, et al.
European Urology
|
August 31, 2017
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)
Hendrik Borgmann, Nada Lallous, Deniz Ozistanbullu, et al.
Plos One
|
December 5, 2025
Complications and oncologic outcome in bladder cancer patients receiving radical cystectomy after intravesical instillation treatment
Lisa J Frey, Katarzyna E Banasiewicz, Christian Ruckes, et al.
Page
of 30